医学
前列腺癌
腺癌
前列腺
流行病学
肿瘤科
内科学
监测、流行病学和最终结果
阶段(地层学)
癌症
数据库
癌症登记处
计算机科学
生物
古生物学
作者
Jun Zhou,Jie Ding,Jun Qi
标识
DOI:10.1016/j.eururo.2022.02.006
摘要
There are currently few large-scale studies describing the clinical characteristics of these histological variants of prostate cancer (PCa) and the prognostic results of these patients. Thus, we used the Surveillance, Epidemiology, and End Results (SEER) database to achieve a more comprehensive understanding of the current prevalence and prognosis of these histological variants. A total of 780 (3.3%) patients with histological variants and 235 834 patients with typical adenocarcinoma were included in the present study. The variants group presented with a more advanced stage than the typical adenocarcinoma group. The results also showed that patients with neuroendocrine (NE) PCa were more likely to have visceral metastases. In prognostic comparison, we found that variants, except for mucinous, had a worse prognosis than typical adenocarcinoma. Moreover, among these variants, we also discovered that NEPCa patients with low prostate-specific antigen level had the worst survival. In contrast, mucinous PCa had similar overall survival to typical adenocarcinoma. We reported follow-up results for prostate cancer (PCa) patients from the Surveillance, Epidemiology, and End Results database (2004–2016). We focused on the prognosis of PCa with different histological variants and evaluated the risk factors that were significant in predicting poor prognosis. We suggested that neuroendocrine PCa patients should receive active treatment as soon as possible to improve their prognosis. We still need further studies to identify the role of mucinous PCa in patients’ prognosis compared with typical adenocarcinoma.
科研通智能强力驱动
Strongly Powered by AbleSci AI